It has been demonstrated that untreated V600EBRAF melanoma cells exhibit high levels of feedback inhibition in the RAF/MEK/ERK signaling pathway that diminishes the ability of receptor tyrosine kinase signaling to activate ERK [1]. This evidence concerns the gene MAP2K7 and melanoma.